Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer's disease patients

被引：0

作者：

Chatanaka, Miyo K. ^{[1
]}

Prassas, Ioannis ^{[2
]}

Diamandis, Eleftherios P. ^{[3
]}

机构：

[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada

[2] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada

[3] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada

来源：

BMC MEDICINE | 2024年 / 22卷 / 01期

关键词：

Alzheimer's disease; Biomarker; Non-invasive; SMOC1; Neuropentraxin; Diagnostic test; Reference range;

D O I：

10.1186/s12916-024-03270-w

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this commentary, we address a paper published by Johnson et al. by assessing the robustness of their method to discover diagnostic biomarkers in Alzheimer's disease (AD). In addition, we examine how these newly discovered and previously discovered biomarkers, can play a role in assisting patients with AD and those at risk for developing AD, with an emphasis on the translational hurdles that accompany such discoveries.

引用

页数：4

共 50 条

[41] Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms
Osorio, R. S.
Pirraglia, E.
Gumb, T.
Mantua, J.
Ayappa, I.
Williams, S.
Mosconi, L.
Glodzik, L.
de Leon, M. J.
NEURODEGENERATIVE DISEASES, 2014, 13 (2-3) : 163 - 165
[42] Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease
Mila-Aloma, Marta
Suarez-Calvet, Marc
Luis Molinuevo, Jose
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12
[43] Advances in the detection of Alzheimer's disease -: use of cerebrospinal fluid biomarkers
Sjögren, M
Andreasen, N
Blennow, K
CLINICA CHIMICA ACTA, 2003, 332 (1-2) : 1 - 10
[44] Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis
Bjerke, Maria
Engelborghs, Sebastiaan
JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1199 - 1209
[45] Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease
Leuzy, Antoine
Cullen, Nicholas C.
Mattsson-Carlgren, Niklas
Hansson, Oskar
CURRENT OPINION IN NEUROLOGY, 2021, 34 (02) : 266 - 274
[46] Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
Schindler, Suzanne E.
Li, Yan
Todd, Kaitlin W.
Herries, Elizabeth M.
Henson, Rachel L.
Gray, Julia D.
Wang, Guoqiao
Graham, Danielle L.
Shaw, Leslie M.
Trojanowski, John Q.
Hassenstab, Jason J.
Benzinger, Tammie L. S.
Cruchaga, Carlos
Jucker, Mathias
Levin, Johannes
Chhatwal, Jasmeer P.
Noble, James M.
Ringman, John M.
Graff-Radford, Neill R.
Holtzman, David M.
Ladenson, Jack H.
Morris, John C.
Bateman, Randall J.
Xiong, Chengjie
Fagan, Anne M.
ALZHEIMERS & DEMENTIA, 2019, 15 (05) : 655 - 665
[47] Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers
Bridel, Claire
Somers, Charisse
Sieben, Anne
Rozemuller, Annemieke
Niemantsverdriet, Ellis
Struyfs, Hanne
Vermeiren, Yannick
Van Broeckhoven, Christine
De Deyn, Peter P.
Bjerke, Maria
Nagels, Guy
Teunissen, Charlotte E.
Engelborghs, Sebastiaan
BRAIN, 2022, 145 (11) : 4056 - 4064
[48] Brain Ventricular Volume and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Ott, Brian R.
Cohen, Ronald A.
Gongvatana, Assawin
Okonkwo, Ozioma C.
Johanson, Conrad E.
Stopa, Edward G.
Donahue, John E.
Silverberg, Gerald D.
JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (02) : 647 - 657
[49] Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers
Mattsson, Niklas
Andreasson, Ulf
Carrillo, Maria C.
Persson, Staffan
Shaw, Leslie M.
Zegers, Ingrid
Zetterberg, Henrik
Blennow, Kaj
BIOMARKERS IN MEDICINE, 2012, 6 (04) : 401 - 407
[50] Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
Simonsen, A. H.
McGuire, J.
Podust, V. N.
Davies, H.
Minthon, L.
Skoog, I.
Andreasen, N.
Wallin, A.
Waldemar, G.
Blennow, K.
NEUROBIOLOGY OF AGING, 2008, 29 (07) : 961 - 968

← 1 2 3 4 5 →